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Edited by Judit Ova´diAbstract Parkin-co-regulated gene (PACRG) is a gene that
shares a bidirectional promoter with Parkinsons disease-related
Parkin/Park2 gene. Recently, the PACRG gene product was
implicated in the function of ﬂagella. However, its exact function
remains unknown. Here, I assessed the interaction between
PACRG and tubulin. Co-sedimentation experiments revealed
that PACRG directly binds to microtubules and a/b-tubulin het-
erodimers with high aﬃnity. Microscopic studies showed that
PACRG bundles microtubules and forms branched aggregates
with unpolymerized tubulin dimers. The amino acid sequence of
the microtubule-binding region of PACRG is highly conserved
among various organisms, suggesting that tubulin binding is a
basic property of PACRG.
Structured summary:
MINT-6439731, MINT-6439753, MINT-6439768:
PACRG (genbank_protein_gi:169219363), tubulin alpha (uni-
protkb:P02550), tubulin beta (uniprotkb:Q2XVP4) bind
(MI:0407) by cosedimentation (MI:0027)
MINT-6439796:
PACRG (genbank_protein_gi:169219363), tubulin alpha (uni-
protkb:P02550), tubulin beta (uniprotkb:Q2XVP4) bind
(MI:0407) by pull-down (MI:0096)
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Parkin-co-regulated gene (PACRG) was originally identiﬁed
in human genome as a gene whose transcription is co-regulated
with a Parkinsons disease-related gene Parkin/Park2 [1] by a
bidirectional promoter [2]. PACRG has been suggested to
interact with Parkin/Park2 and form a large chaperonin com-
plex with chaperones [3]. Taylor et al. [4] showed that PACRG
is regulated by a ubiquitin-proteasomal system that involves
Parkin/Park2. These observations have thus suggested the
involvement of PACRG in parkinsonism.
Recently, several studies have unexpectedly reported that
PACRG is also present in the ﬂagella of various eukaryotes.
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doublet microtubules in Trypanosoma [6]. Our study of Chla-
mydomonas PACRG showed that it is densely localized along
the ﬂagellar outer doublet microtubules, possibly buried in the
microtubule wall [7]. Despite these ﬁndings, the biochemical
nature and physiological function of PACRG remain to be
studied. Here, I report that PACRG associates with both
microtubules and tubulin dimers in vitro.2. Materials and methods
2.1. Alignment
By BLAST search using the amino acid sequence of C. reinhardtii
PACRG (GenBank Accession No. BAG12189) [7] as the query,
homologous sequences were obtained from T. brucei (XP_843825,
XP_827292), Paramecium tetraurelia (CAK71037, XP_001443020),
Caenorhabditis elegans (NP_495496), Tetrahymena thermophila
(XP_001023392, XP_001022215, XP_001022189), Strongylocentrotus
purpuratus (XP_791188, XP_784874), Drosophila melanogaster
(NP_609957, XP_843825), Apis mellifera (XP_625146), Danio rerio
(NP_001007399), Mus musculus (NP_081308), and Homo sapiens
(AAH30642). Alignment was created using CLUSTALW ver. 1.83 [8].
2.2. Preparation of PC-tubulin
Puriﬁed a/b-tubulin heterodimer (PC-tubulin) was obtained from
porcine brain by cycles of temperature-dependent polymerization
and phosphocellulose chromatography [9].
2.3. In vitro synthesis and stabilization of microtubules
PC-tubulin was polymerized by incubation at 37 C in a tubulin
assembly buﬀer (80 mM PIPES, 1 mM MgCl2, 1 mM EGTA, 1 mM
GTP, pH 6.8) containing 20% (v/v) dimethyl sulfoxide. Microtubules
were stabilized by addition of 20 lM taxol and collected by centrifuga-
tion at 30 C. The precipitated microtubules were washed with the
tubulin assembly buﬀer containing 20 lM taxol and resuspended in
an appropriate volume of the buﬀer.
2.4. Expression and puriﬁcation of recombinant PACRG proteins
Recombinant PACRG proteins were expressed using the Bac-to-Bac
Baculovirus Expression Systems (Invitrogen, Carlsbad, CA). Total
RNA was prepared from wild-type C. reinhardtii cells using TRIzol
Reagent (Invitrogen) and ﬁrst strand cDNA was synthesized by Super-
Script II reverse transcriptase (Invitrogen) using an oligo(dT)12–18 pri-
mer. Using it as the template, the cDNAs encoding the full-length and
truncated coding sequences of PACRG were ampliﬁed by PCR using
the primer sets, PACRG_BamHI_F [5 0-CGG GAT CCA TGA ACG
GAG ACG TGG C-3 0] and PACRG + 6His_EcoRI_R [5 0-CGG
AAT TCA GTG ATG GTG ATG GTG ATG TGC GTA GTT
CAC GCT GG-3 0] (full length), PACRG301 + ATG_BamHI_F [5 0-
CGG GAT CCA TGA AGC CGT CCC CAC CTC AAG-3 0] and
PACRG + 6His_EcoRI_R (DN), PACRG_BamHI_F and PAC-
RG852 + 6His_EcoRI_R [5 0-CGG AAT TCA GTG ATG GTG
ATG GTG ATG CTT TTG CTC GAA CAG CG-3 0] (DC1), PAC-
RG_BamHI_F and PACRG693 + 6His_EcoRI_R [5 0-CGG AAT
TCA GTG ATG GTG ATG GTG ATG CAC CAG GTC CGCblished by Elsevier B.V. All rights reserved.
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RG693 + 6His_EcoRI_R (DNC2). The PCR products were ligated
into pFastBac1 vector (Invitrogen). Baculoviruses expressing 6· His-
tagged PACRG proteins were produced according to manufacturers
recommendations. Sf9 insect cells (Invitrogen) infected with the viruses
were lysed in a lysis buﬀer (0.6 M NaCl, 50 mM NaH2PO4, 10 mM
imidazole, 0.1% TritonX-100) and the PACRG recombinants fused
to 6· His-tag were primarily puriﬁed using Ni-NTA Agarose (QIA-
GEN, Valencia, CA). Subsequently, these solutions were fractionated
by gel ﬁltration using Superdex 200 PC 3.2/30 column (GE Healthcare
UK Ltd.) in SMART System (GE Healthcare UK Ltd.), and the frac-
tions containing pure PACRG proteins were collected. This fraction-
ation step was not carried out for the DC2 and the DNC2
recombinants because these recombinants were obtained at very low
levels in a soluble state. These solutions were dialyzed against the tubu-
lin assembly buﬀer to be subjected to the following experiments. For
negative control for microscopic studies (see below), solutions from
baculovirus/Sf9 that do not express recombinant PACRG were also
prepared in the same way as those from the recombinant PACRG-
expressing cells.
2.5. Microtubule co-sedimentation assay
The recombinant PACRG proteins were mixed with stabilized
microtubules in the tubulin assembly buﬀer containing 0.1% Triton
X-100 and 20 lM taxol. After incubation at 37 C, microtubules were
collected by centrifugation and washed with the buﬀer. Both the pre-
cipitates and the supernatants were analyzed by SDS–PAGE. The
presence of the recombinant PACRG proteins were detected by stain-
ing with Coomassie brilliant blue (CBB).
2.6. Quantitative analysis of PACRG-microtubule interactions
For quantiﬁcation of microtubule-PACRG binding, varying
amounts of the full-length and truncated PACRG recombinants were
mixed with microtubules at a constant concentration of tubulin hetero-
dimer. PACRG proteins that were bound and not bound to microtu-
bules were separated by centrifugation and analyzed by SDS–PAGE.
Quantities of both bound and unbound PACRG in the CBB-stained
SDS–PAGE gel were estimated by densitometry using a CS Analyzer
(ATTO, Tokyo, Japan). Data for a given set of conditions were those
averaged from 4 to 5 experiments.
2.7. His-tag pull-down assay
PC-tubulin was diluted below the critical concentration for polymer-
ization with a pull-down buﬀer (80 mM PIPES, 1 mM MgCl2, 1 mM
EGTA, 0.1 mM GTP, 0.1% Triton X-100, 5 mM colchicine, pH 6.8).
Subsequently, PACRG was mixed with this solution containing 1%
BSA, and incubated. After insoluble proteins were removed by centri-Fig. 1. PACRG directly binds to microtubules. Microtubule co-sedimentatio
(A) Puriﬁcation of recombinant PACRG using sequential puriﬁcation steps.
was puriﬁed by aﬃnity chromatography on a nickel column and gel ﬁltration.
with CBB. (B) Co-precipitation of recombinant PACRG with taxol-stabilized
They were co-precipitated. In contrast, PACRG without microtubules was no
b-tubulin heterodimers. His-tag pull-down assay was carried out under condit
that PACRG binds to unpolymerized tubulin.fugation, the solution was mixed with Ni-NTA Agarose (QIAGEN).
After incubation, the beads were washed with the buﬀer and the bound
proteins were eluted with an elution buﬀer (80 mM PIPES, 1 mM
MgCl2, 1 mM EGTA, 0.1 mM GTP, 0.1% Triton X-100, 5 mM colchi-
cine, 300 mM imidazole, pH 6.8). All procedures were carried out at
4 C. The eluates were analyzed by SDS–PAGE followed by CBB
staining.
2.8. Dark-ﬁeld and electron microscopic observations
Microtubules were mixed with PACRG in the assembly buﬀer con-
taining 0.1% Triton X-100 and 20 lM taxol, and incubated at 37 C.
As a negative control, microtubules were mixed with solutions that
had been obtained from baculovirus/Sf9 cells not expressing recombi-
nant PACRG. These mixtures were diluted to appropriate concentra-
tions with the same buﬀer and observed using a dark-ﬁeld microscope
BX50 (OLYMPUS, Tokyo, Japan). For negative-staining electron
microscopy, the mixtures were negatively stained with 1% uranyl ace-
tate. For thin-section observations, the PACRG-microtubules/tubulin
complexes were collected by centrifugation and ﬁxed with 2% glutaral-
dehyde and 1% OsO4. Samples were dehydrated, embedded in
EPON812 resin, thin-sectioned and stained with uranyl acetate and
lead citrate. These specimens were observed using JEM1010 electron
microscope (JEOL Ltd., Tokyo, Japan). For observation of tubulin
in the presence of PACRG, tubulin was mixed with PACRG below
the critical concentration for polymerization in the presence of 5 mM
colchicine at room temperature. The solutions were observed using
the dark-ﬁeld microscope.3. Results
3.1. PACRG directly binds to taxol-stabilized microtubules and
unpolymerized tubulin heterodimers
We have found that PACRG is associated with the outer
doublet microtubules in the Chlamydomonas axoneme [7]. To
examine whether PACRG directly binds to microtubules or
not, I conducted a co-sedimentation assay using microtubules
polymerized from brain PC-tubulin and recombinant PACRG.
Recombinant PACRG had been produced by baculovirus/in-
sect cells and extensively puriﬁed using aﬃnity chromatogra-
phy on a nickel column and gel ﬁltration. SDS–PAGE
indicated that it was highly puriﬁed (Fig. 1A). When the puri-
ﬁed PACRG was incubated with taxol-stabilized microtubules
and then centrifuged, a large portion of the PACRG was pre-n assay shows a direct association between PACRG and microtubules.
Chlamydomonas PACRG produced in a baculovirus/insect cells system
The puriﬁed protein was subjected to SDS–PAGE followed by staining
microtubules. PACRG was mixed with microtubules and centrifuged.
t precipitated. (C) Direct association of PACRG with unpolymerized a/
ions where tubulin does not polymerize. SDS–PAGE analysis indicates
Fig. 2. Microtubule-binding property resides in the conserved region of PACRG. (A) Alignment of PACRG amino acid sequences of various
eukaryotes. A large portion of PACRG is well conserved among organisms while its N-terminal region is divergent. Underlined sequences indicate the
regions that are missing in the recombinant proteins used in B and C (green), D and E (red), and F (green and blue). Highly conserved residues are
highlighted in dark gray, and residues conserved in the majority of sequences are highlighted in light gray. (B) High purity of the truncated recombinant
protein that lacks the N-terminal region (DN) as assessed by SDS–PAGE. (C) The recombinant PACRG protein that lacks the N-terminal region binds
to microtubules although its aﬃnity is attenuated. The truncated PACRG recombinant was mixed with microtubules and separated into precipitated
and supernatant fractions by centrifugation. The amount of the truncated PACRG used was the same as that of the full-length protein used in Fig. 1C.
(D) High purity of the truncated recombinant protein that lacks the C-terminal 23 residues (DC1, underlined in red in A) as assessed by SDS–PAGE. (E)
The recombinant PACRG that lacks the C-terminal 23 residues binds to microtubules although its aﬃnity is attenuated. The amount of the protein was
the same as that of the full-length protein used in Fig. 1C. (F) The recombinant protein that lacks the C-terminal 76 residues (underlined in blue in A),
and the recombinant protein that lacks both of the 76-residue-C-terminus (underlined in blue in A) and the N-terminus (underlined in green in A), bind
to microtubules. The amounts of the recombinants used were smaller than that of the full-length protein used in Fig. 1C.
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when centrifuged without incubation with microtubules
(Fig. 1B). Essentially the same result was obtained when the
buﬀer contained 1% BSA (data not shown). These results indi-
cate direct binding between microtubules and the recombinant
PACRG.
Next, to determine whether PACRG directly binds to unpo-
lymerized tubulin dimers also, I carried out a His-tag pull-
down assay using Ni-agarose beads. Tubulin and Ni-agarose
beads were mixed with 6· His-tagged PACRG at 4 C in the
presence of 5 mM colchicine at a tubulin concentration lower
than the critical concentration for polymerization. They were
centrifuged after incubation, and the proteins bound to theFig. 3. PACRG-induced formation of microtubule bundles and branched
microtubules in the absence (upper, left panel) and presence (upper, right pan
panels) and thin-sectioned (lower panels) microtubules in the absence (left pan
of unpolymerized tubulin in the absence (left panel) and presence (right panel
stained samples), or 100 nm (thin-sectioned samples).beads were eluted with an imidazole-containing buﬀer. SDS–
PAGE indicated that PACRG is directly associated with unpo-
lymerized tubulin dimers (Fig. 1C).
3.2. Microtubule-binding property is present in the conserved
region of PACRG
Blast search showed that the sequences homologous to
PACRG are conserved within a wide range of ﬂagellate
eukaryotes and C. elegans, suggesting that PACRG plays an
important role in the cilia/ﬂagella as suggested by the previous
studies [5–7] (Fig. 2A). Some organisms such as Trypanosoma
[6] were found to have multiple PACRG-homologous se-
quences.aggregates of unpolymerized tubulin. (A) Dark-ﬁeld micrographs of
el) of PACRG, and electron micrographs of negatively stained (middle
els) and presence (right panels) of PACRG. (B) Dark-ﬁeld micrographs
) of PACRG. Bars: 10 lm (dark-ﬁeld micrographs), 200 nm (negatively
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cept for the N-terminal region (Fig. 2A). To determine whether
the tubulin-binding nature resides in the conserved region or
not, I carried out a co-sedimentation assay using a recombi-
nant PACRG that lacks the Chlamydomonas-speciﬁc N-termi-
nal region (Fig. 2A and B). As shown in Fig. 2C, this truncated
PACRG became bound to microtubules although its aﬃnity
was attenuated. This result indicates that the conserved region
contains microtubule-binding domain(s) and suggests that the
microtubule-binding property may well be common to the
PACRG of other organisms.
While moderately conserved region extends over 180 resi-
dues, there is an ultra-conserved region at the extreme C-termi-
nus (Fig. 2A, red underline). To examine whether this region is
essential for the microtubule-binding of PACRG, I performed
a co-sedimentation assay using a truncated PACRG that lacks
this region (Fig. 2D). This truncated PACRG was found to
bind with microtubules (Fig. 2E). However, the binding of this
truncated protein saturated at about two thirds of the concen-
tration at which the full-length PACRG saturates (Fig. S1).
Thus, it is possible that the extreme C-terminal region contains
a site that binds to tubulin at a site diﬀerent from the site to
which other PACRG regions bind. I also examined the micro-
tubule-binding activity in PACRG recombinants that lack
either the C-terminal 76 residues (Fig. 2A, blue underline)
(DC2) or both of the N-terminus (Fig. 2A, green underline)
and the C-terminal 76 residues (Fig. 2A, blue underline)
(DNC2), and found that these proteins also bind with microtu-
bules (Fig. 2F). These results suggest that at least the middle
region contains microtubule-binding site(s).
3.3. PACRG bundles microtubules and forms branched
aggregates with unpolymerized tubulin dimers
To examine the eﬀects of PACRG on the gross appearance
of microtubules, I observed taxol-stabilized microtubules by
dark-ﬁeld microscopy after addition of PACRG. As shown
in Fig. 3A, microtubules formed thick bundles in the presence
of PACRG. No such bundle was observed when microtubules
were mixed with solutions obtained from baculovirus/insect
cells not expressing recombinant PACRG (data not shown).
I also observed tubulin heterodimers in the presence of col-
chicine and PACRG at tubulin concentrations below the crit-
ical concentration for polymerization, and found that many
branched aggregates were formed in the solution (Fig. 3B).
Electron microscope observations indicated that the aggre-
gates did not contain any microtubule-like structures (data
not shown).
Finally, tubulin was polymerized in the presence of PACRG.
This resulted in production of a large amount of branched
aggregates, in addition to microtubule bundles (data not
shown).4. Discussion
In the present study, I demonstrated that PACRG is directly
associated with microtubules and tubulin dimers (Figs. 1 and
3). Previously, PACRG was found to be present along the out-
er doublet microtubules but exposed only after the B-tubule is
partially disrupted [7]. Recent studies using cryo-electron
tomography have shown that various discrete structures are at-tached between the A- and B-tubules and within and inside the
microtubule walls [10,11]. PACRG may constitute such a
structure, and play an important role in the doublet microtu-
bule assembly [6]. In this context, the observations that PAC-
RG can bind with both microtubules and tubulin dimers (Figs.
1 and 3) are interesting. Tubulin polymerization in the pres-
ence of PACRG resulted in the formation of a large amount
of aggregates in addition to normal microtubule bundles
in vitro. The aggregates are most likely produced by non-stoi-
chiometric association. However, it is conceivable that PAC-
RG is integrated in the microtubule cytoskeleton in an
ordered manner in vivo [7]. The exact mode of PACRG-tubu-
lin interaction in vivo, as well as in vitro, awaits further studies
that quantify the interaction and examine whether or not
PACRG itself forms a homo-dimer or a homo-oligomer.
PACRG is expressed in various tissues of mammals [5,12].
Although I examined only Chlamydomonas PACRG in this
study, tubulin-binding properties may well be common to
the PACRG of other organisms (Fig. 2). In support of this
idea, previous studies have provided indirect evidence for
PACRG-tubulin interaction. For example, Imai et al. [3] de-
tected a- and b-tubulin as PACRG-associated proteins by
immunoprecipitation from the lysates of human embryonic
kidney cells that over-express PACRG. In addition, Taylor
et al. [4] showed that the localization of PACRG in neurons
of the locus coeruleus in the progressive supranuclear neuron
palsy brain is displaced by hyperphosphorylated tau, a micro-
tubule-associated protein [13–15].
Abnormalities in the promoter region of Parkin/Park2 and
PACRG are implicated in various human diseases that include
leprosy [12,16,17], typhoid and paratyphoid fever [18], and leu-
kemia [19], as well as in male sterility [5] and Parkinsons dis-
ease [3,4]. Considering such a wide range of abnormalities for
which PACRG may be responsible, PACRG can be involved
in some fundamental cellular function. It may well be related
to its activity to bind with tubulin and microtubules.
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